Recent News

May 17, 2022

scPharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Read More
May 16, 2022

scPharmaceuticals Inc. Reports First Quarter 2022 Financial Results and Provides Business Update

Read More
May 16, 2022

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

Read More
April 11, 2022

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application

Read More